We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+6.57%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$49.1B
AUM Growth
+$4.31B
Cap. Flow
+$1.72B
Cap. Flow %
3.51%
Top 10 Hldgs %
14.46%
Holding
3,114
New
67
Increased
2,155
Reduced
468
Closed
57

Sector Composition

Rank Sector Weight
1 Financials 14.36%
2 Healthcare 13.62%
3 Technology 13.02%
4 Industrials 11.1%
5 Energy 9.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HTBK
2901
DELISTED
Heritage Commerce
HTBK
$212K ﹤0.01%
27,900
-19,400
-41% -$140K
MPX
2902
DELISTED
Marine Products Corp
MPX
$209K ﹤0.01%
22,888
+1,261
+6% +$11.2K
MRIN
2903
DELISTED
Marin Software
MRIN
$208K ﹤0.01%
406
+14
+4% +$7.37K
LOV
2904
DELISTED
Spark Networks SE American Depositary Shares
LOV
$208K ﹤0.01%
25,100
ZLTQ
2905
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$208K ﹤0.01%
23,000
DOC
2906
DELISTED
PHYSICIANS REALTY TRUST
DOC
$208K ﹤0.01%
+16,800
New +$196K
SSNI
2907
DELISTED
Silver Spring Networks, Inc.
SSNI
$207K ﹤0.01%
11,950
+1,525
+15% +$34.6K
GYRE icon
2908
Gyre Therapeutics
GYRE
$749M
$206K ﹤0.01%
47
MCHX icon
2909
Marchex
MCHX
$79.3M
$205K ﹤0.01%
28,600
STRL icon
2910
Sterling Infrastructure
STRL
$16.2B
$204K ﹤0.01%
22,000
IBCA
2911
DELISTED
INTERVEST BANCSHARES CORP COM
IBCA
$204K ﹤0.01%
25,500
VSB
2912
DELISTED
VANTAGESOUTH BANCHARES, INC
VSB
$204K ﹤0.01%
38,600
+25,600
+197% +$132K
PMFG
2913
DELISTED
PMFG INC COM STK (DE)
PMFG
$203K ﹤0.01%
27,700
IHC
2914
DELISTED
Independence Holding Company
IHC
$203K ﹤0.01%
14,218
FNLC icon
2915
First Bancorp
FNLC
$393M
$202K ﹤0.01%
12,096
LCTX icon
2916
Lineage Cell Therapeutics
LCTX
$286M
$201K ﹤0.01%
63,190
-23,421
-27% -$74.1K
FLXS icon
2917
Flexsteel Industries
FLXS
$307M
$200K ﹤0.01%
8,100
NATH icon
2918
Nathan's Famous
NATH
$400M
$200K ﹤0.01%
3,700
ISH
2919
DELISTED
INTL SHIPHOLDING CORP
ISH
$200K ﹤0.01%
+7,300
New +$184K
SLTM
2920
DELISTED
SOLTA MED INC (DE)
SLTM
$200K ﹤0.01%
95,100
MSPD
2921
DELISTED
MINDSPEED TECHNOLOGIES INC COM STK
MSPD
$198K ﹤0.01%
64,400
IMN
2922
DELISTED
Imation
IMN
$197K ﹤0.01%
45,700
GSOL
2923
DELISTED
Global Sources Ltd
GSOL
$195K ﹤0.01%
25,900
URG
2924
Ur-Energy
URG
$564M
$194K ﹤0.01%
173,000
TTPH
2925
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$194K ﹤0.01%
820

Similar funds

Charles Schwab's Q3 2013 Portfolio in Review

As of Q3 2013, Charles Schwab held 3,114 positions worth $49.1B, up 9.6% from $44.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Charles Schwab deployed $1.72B of net new capital in Q3 2013, opening 67 new positions and adding to 2,155 existing holdings. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 4,003,512 shares worth $136M.

By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Merck, an estimated $76M trimmed.

  • Charles Schwab's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 4,003,512 shares worth $136M.
  • Charles Schwab added most to Johnson & Johnson in Q3 2013, an estimated $125M increase.
  • Charles Schwab's biggest Q3 2013 reduction was Merck, cutting an estimated $76M.
  • Charles Schwab fully exited SPRINT CORP FON COM in Q3 2013, selling an estimated $47.2M.
  • Charles Schwab's ten largest holdings make up 14% of its $49.1B portfolio in Q3 2013.
  • Charles Schwab opened 67 new positions and closed 57 in Q3 2013.
  • Charles Schwab's portfolio value rose 9.6% quarter-over-quarter to $49.1B.

Based on Charles Schwab's 13F filing for Q3 2013, filed 14 Nov 2013.